Approximately 70% of XGEVA® patients with commercial or Medicare coverage are expected to have $0 out-of-pocket cost1
XGEVA FIRST STEP™ can help your eligible commercially insured patients meet their out-of-pocket costs†
The XGEVA FIRST STEP™ Program may help eligible commercially insured patients meet their deductible, co-insurance, and co-payment.
XGEVA FIRST STEP™
- No out-of-pocket cost for the first dose
- No income eligibility requirement
- For subsequent doses, Amgen will pay the out-of-pocket amount in excess of $25 per dose, up to $10,000 in assistance per calendar year†
Eligibility Criteria: Patient must be prescribed XGEVA®. Patient must have private commercial health insurance that covers medication costs for XGEVA®. Patient must not be a participant in any federal-, state-, or government-funded healthcare program such as Medicare, Medicare Advantage, Medicare Part D, Medicaid, Medigap, Veterans Affairs (VA), the Department of Defense (DoD), or TRICARE. Patient may not seek reimbursement for value received from the Amgen FIRST STEP™ program from any third-party payers, including flexible spending accounts or healthcare savings accounts. If at any time patients begin receiving coverage under any federal-, state-, or government-funded healthcare program, patients will no longer be eligible to participate in the Amgen FIRST STEP™ Program and must call 1-888-65-STEP11-888-65-STEP1 (1-888-657-83711-888-657-8371) Monday through Friday, 9 am-8 pm EST, to stop participation. Restrictions may apply. Amgen reserves the right to revise or terminate this program, in whole or in part, without notice at any time. This is not health insurance. Program invalid where otherwise prohibited by law. Register before any treatment. Other restrictions apply. Amgen reserves the right to revise or terminate this program, in whole or in part, without notice at any time.
Coverage Limits: Program covers out-of-pocket medication costs for XGEVA® only. Program does not cover any other costs related to office visit or administration of XGEVA®. No out-of-pocket for first dose; $25 out-of-pocket cost for subsequent dose; maximum benefit of $10,000 per patient per calendar year. Patient is responsible for costs above these amounts. Ongoing activation of the Amgen FIRST STEP™ card is contingent on the submission of the required Explanation of Benefits (EOB) form by the healthcare provider’s office within 45 days of use of the Amgen FIRST STEP™ card. Patients will be responsible for reimbursing the program for all amounts paid out if the EOB for the date of service is not received within 45 days.
*Estimated amount of Medicare beneficiaries with supplemental coverage and commercially insured patients with no out-of-pocket cost; based on XGEVA® payor mix and coverage of XGEVA® in patients with bone metastases and solid tumors, and other similar products. Does not include costs related to office visit, physician, staff, or administrative charges associated with administering XGEVA®.
Amgen can connect eligible Medicare patients to independent third party co-pay foundations‡
- Amgen Assist® can provide information to your patients on the following co-pay foundations
- Patient Access Network Foundation
- Patient Advocate Foundation Co-pay Relief
- HealthWell Foundation
- Providers can contact the independent co-pay foundations directly or through Amgen Assist®.
‡Assistance is provided through third-party 501(c)(3) tax-exempt nonprofit organizations and based on the program eligibility requirement of those organizations.
The Safety Net Foundation helps eligible uninsured or underinsured patients access XGEVA® at no cost
The Safety Net Foundation is a nonprofit patient assistance program that provides Amgen products at no cost to qualifying patients with no or limited drug coverage who meet income eligibility requirements.